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Objective: To study the association between change in the body mass index (BMI) at different ages and
the risk of a later total hip replacement (THR) due to primary osteoarthritis (OA).
Design: A total of 265,725 individuals who had two repeated measurements of weight and height were
included from national health screenings. These individuals were followed prospectively. The data were
matched with the Norwegian Arthroplasty Register and 4,442 of these individuals were identiﬁed as
having received a THR for primary OA. Cox proportional hazard regression was used to calculate sex-
speciﬁc relative risks for having a THR according to age at screening and BMI change.
Results: Men and women aged 20 years or younger at the ﬁrst screening in the quartile with the greatest
BMI change per year had more than twice the risk of later having a THR compared with those in the
quartile with the smallest BMI change per year. For men older than 30 years at the ﬁrst screening, there
was no relationship between BMI gain, or weight gain, and later risk of THR. For older women, BMI gain
was associated with risk of THR, but to a lesser degree than in younger women.
Conclusion: There was a clear relationship between change in BMI and the risk of later THR in young men
and women, whereas the association was absent in older men and weaker in older women. It is
important to focus on weight control to prevent future OA, and the preventive strategy should be focused
on the young population.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Knowledge of the pathogenesis and risk factors for hip osteo-
arthritis (OA) is increasing. A strong hereditary component has
been identiﬁed1e4, and high body mass index (BMI), and high
physical activity are established as strong risk factors5e12, as is
previous joint injury13,14.
BMI is a modiﬁable risk factor; therefore, studies of the effect of
weight change on development, progression and treatment of OA
would provide valuable information that could be used to advise
people about lifestyle changes to prevent future OA.
Weight reduction has proven effective in relieving pain in
symptomatic knee OA15, and it has been associated with lower risk
of knee OA later in life16. Weight gain from normal to obese weight
in adult life has also been shown to lead to a higher risk for needingto: H. Apold, Orthopaedic
way. Tel: 00-47-95-87-71.
old).
s Research Society International. Pa total knee replacement17. An increase in BMI in early adult life was
associated more strongly with later knee OA than an increase in
BMI in middle age18.
Two studies have investigated the effect of weight change on the
risk of having a total hip replacement (THR). One study examined
the effect of spontaneous weight change between ages 34 and 47
years in 38,868 men and women and found no effect19. The Nurses’
Health Study included 93,442 female nurses and found a moderate
effect of weight gain from the age of 18 years until the date of THR,
and no effect of weight loss20. A third study investigated the effect
of weight change between ages 20 and 49 years on self-reported
hip OA in 1,180 male physicians18. This study found no effect of
weight change, but with only 26 men reporting hip OA, the power
to detect an association was limited.
In the Nurses’ Health Study, the recalled BMI at 18 years was
highly associated with later THR, more than BMI close to the date of
THR20. A large cohort study of almost 1.2 million individuals also
found that the impact of a high BMI on the risk of having a later THRublished by Elsevier Ltd. All rights reserved.
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OA is established early in life.
Animal studies have revealed changes in the architecture and
collagen content of the cartilage during growth and maturation22.
The timescale of this maturation in humans is not elaborated. The
authors of the animal study indicate that regular physical exercise
with physiological loading at a young age may prevent future OA.
The current study investigates the effect of change in BMI on the
risk of having a THR for primary OA. Previous studies have found no
effect of weight gain in middle age19, but a difference in the impact
of a high BMI between different age groups21; therefore, this study
assesses the effect of weight gain in subgroups of patients according
to age. The study hypothesis is that weight gain in young adults is
more damaging to the hip joint than weight gain later in life.
Patients and methods
The National Health Screening Service (now the Norwegian
Institute of Public Health) has performed a series of population-
based health screenings in Norway, including a nationwide
compulsory tuberculosis screening during 1963e197523, and
numerous cardiovascular screenings from 1974 to 199924. In addi-
tion, population-based health screenings have been performed in
the city of Oslo25, Tromsø26, and the county of Nord-Trøndelag27.
Information obtained in the screenings varies according to the
different purposes of the screenings.We gathered information from
these surveys on weight and height measured twice in 304,011
individuals. The ﬁrst weight and height measurements were from
screenings performed between 1963 and 1975; the Tuberculosis
Screening23, and the Oslo Study25. The second weight and height
measurements were obtained from screenings performed between
1974 and 1997; the First and Second Cardiovascular Survey of
Oppland, Finnmark and Sogn og Fjordane, the Second and the Third
Tromsø Study, the First Nord-Trøndelag Health Study (HUNT), and
the 40-year Surveys. Body weight and height were measured in
a standardized way at a consultation in all the included screenings.
The second screening also included information on smoking habits,
which were classiﬁed as never smoker, former smoker, or current
smoker. Data from the health surveys were matched with the data
on THRs performed from the Norwegian Arthroplasty Register
using the national 11-digit personal identiﬁcation code. The
Norwegian Arthroplasty Register was started in 1987 by the
Norwegian Orthopedic Association28. The operating orthopedic
surgeon submits a standardized form to the register for each
arthroplasty performed. The form contains information about the
patient, the diagnosis that leads to the arthroplasty, the procedure
and the type of implant used. The Norwegian Arthroplasty Register
was fully operational from 1989. Data on death and emigration
were collected from the Norwegian Registry of Vital Statistics.
The start of follow up in this studywas January 11989, except for
individuals who had their second weight measured in a health
survey performed later than January 1 1989. For these, the start of
follow up was the date of the second weight measurement. End of
follow up was February 1 2006. There is no information on THRs
performed before the start of follow up, except for 242 cases where
there is information on surgery performed before the start of follow
up that was given in connection with later surgery and is found in
the Norwegian Arthroplasty Register. These cases were excluded.
Inclusion: all individuals invited to the Tuberculosis Screening
or the Oslo Study who also participated in later screenings, and so
had their weight and height recorded twice, were included in the
study.
Exclusion: all individuals younger than 16 years at the ﬁrst
screening (n¼ 29,764), or older than 80 years at the start of follow
up (n¼ 2,816) were excluded. Individuals were also excluded ifthey: had their second weight and height measurement after they
had received a THR (n¼ 133); had already received a THR before
start of follow up, according to the Norwegian Arthroplasty Register
(n¼ 242), or had died or emigrated before start of follow up,
according to the Norwegian Registry of Vital Statistics (n¼ 4,864).
Also excluded were individuals who had information in the register
about revision surgery, but no information on primary surgery, and
individuals for whom there were irregularities in the data from the
Norwegian Arthroplasty Register (n¼ 467).
A total of 304,011 individuals had repeated measurements of
weight and height. Of these, 265,725 were eligible for the study
after exclusion.
BMI was calculated as weight (in kilograms) divided by height
(in meters) squared. Change in body stature was expressed as
change in BMI per year: the difference in BMI between the last and
the ﬁrst screening divided by the number of years between the
screenings (ΔBMI/Year). The cohort was divided into quartiles
according to the change in BMI per year and the quartiles with
greater changes in BMI per year were compared with the quartile
with the least change in BMI per year (the reference quartile). There
are some limitations to the use of change in BMI per year as an
exposure variable. There is no information on howeach individual’s
stature evolved between the two screenings, e.g., if he or she gained
weight rapidly during 1 year, or if the weight change was gradual
throughout the whole interval between the two screenings.
Because of this uncertainty, the analyses were also performed using
absolute weight change in kilograms between the two screenings.
The cohort was divided into strata of 10 years according to the
age at the ﬁrst screening, and the results are presented accordingly.
For example, for the strata who were 20 years and younger at the
ﬁrst screening, the effect of weight change between screenings was
studied at mean ages of 18 and 41 years (Table I). The cohort was
also stratiﬁed by sex.
Adjustments were made for the continuous variables age, BMI
and height at the ﬁrst screening, and for the smoking habits
recorded at the second screening. Analyses were also performed
with BMI and height measured at the ﬁrst screening, categorized
into sex-speciﬁc quartiles.
The analyses were performed as a survival study using the Cox
proportional hazard regression method, calculating hazard ratios
(hereafter called relative risks) for having a THR. The event was
deﬁned as the ﬁrst recorded THR performed for the diagnosis of
primary OA. Censoring occurred for THR performed for diagnosis
other than primary OA, for death, for emigration, and at end of
follow up.
Tests and visual inspection of plotted scaled Schoenfeld resid-
uals29 showed that the proportional hazard assumption of the Cox
model was satisﬁed. The analyses were performed using the
statistical program package SPSS version 16 (SPSS Inc., Chicago, IL,
USA), and the statistical software R, version 2.9.0 (R: A language and
environment for statistical computing. Foundation for Statistical
Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.
R-project.org).
The study was approved by the Data Inspectorate and the
Regional Committee for Research Ethics in Norway.
The numbers of individuals included in the tables may vary
slightly due to some missing values.
Results
A total of 124,894men and 140,831womenwere included in the
study. The mean time between the two screenings was 18.1 years
[standard deviation (SD) 4.8] and was somewhat longer in the
youngest age group (Table I). Mean follow-up time was 15.3 years
(SD 2.5). Themean increase in BMI between the two screenings was
Table I
Background characteristics of the cohort of 265,725 participants according to age at the ﬁrst screening
Age group at ﬁrst screening (y)
20 21e30 31e40 41e50 51e60
Men
No. 46,606 44,665 20,610 10,038 2,969
Age at ﬁrst screening (1963e1975)* 17.8 (1.3) 24.4 (2.6) 35.6 (2.8) 44.4 (2.6) 54.6 (2.6)
Years between screenings* 21.8 (3.5) 16.5 (3.3) 13.4 (4.5) 16.4 (4.5) 16.0 (1.5)
Age at second screening (1974e1997)* 40.2 (3.4) 41.3 (2.7) 49.5 (5.6) 61.3 (5.7) 71.1 (2.8)
Age at start of follow up (01.01.1989, or for persons with second
screening after 01.01.1989, date for second screening)*
40.9 (1.6) 43.9 (3.1) 56.7 (3.9) 65.2 (3.0) 75.0 (2.7)
Age at end of follow up (01.02.2006)* 54.6 (2.2) 60.2 (3.6) 73.1 (3.6) 80.9 (2.5) 90.5 (2.4)
Women
No. 51,417 52,783 21,875 11,105 3,647
Age at ﬁrst screening (1963e1975)* 17.9 (1.4) 24.1 (2.6) 35.6 (2.8) 44.5 (2.6) 54.6 (2.6)
Years between screenings* 21.9 (3.4) 16.7 (3.3) 13.9 (4.7) 16.9 (4.2) 16.0 (1.5)
Age at second screening (1974e1997)* 40.3 (3.3) 41.3 (2.6) 50.0 (5.8) 61.9 (5.4) 71.1 (2.8)
Age at start of follow up (01.01.1989, or for persons with second
screening after 01.01.1989, date for second screening)*
41.0 (1.6) 43.8 (3.1) 56.9 (4.0) 65.4 (2.9) 75.1 (2.7)
Age at end of follow up (01.02.2006)* 54.7 (2.3) 60.1 (3.7) 73.5 (3.5) 81.2 (2.6) 90.8 (2.4)
* Mean (SD).
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with a corresponding mean increase in weight of 8.4 kg (SD 8.4) in
men, and 5.1 kg (SD 8.3) inwomen (Table II). During follow up,1,521
men, and 2,921 women received their ﬁrst THR because of primary
OA. A total of 1,945 individualswere censored because they received
the prosthesis for a condition other than primary OA. The main
indications for surgery in these cases were dysplasia (n¼ 705) and
sequelae after hip fracture (n¼ 616). A total of 30,980 individuals
were censored because they died or emigrated during follow up.
The cohort was divided into groups according to age at the ﬁrst
screening. Men aged 20 years or younger in the quartile with the
greatest BMI change per year had a more than double relative risk
of having a THR compared with men in the same age group in the
quartile with the smallest BMI change per year. The corresponding
relative risk inmen aged 21e30 years at the ﬁrst screeningwas 37%.
There was no statistically signiﬁcant increased risk associated with
change in BMI in men aged over 31 years at the ﬁrst screening
(Table III).
For women aged 20 years or younger at the ﬁrst screening, the
relative risk of having a THR in the quartile with the greatest BMI
change per year was also more than double that in the quartile with
the smallest BMI change per year. An increased relative risk for
women in the quartile with the greatest BMI change per year
compared with that with the smallest BMI change per year was
found to a lesser degree in those aged 21e30 years, and 31e40
years at the ﬁrst screening. In the oldest age group of women,Table II
Change in BMI, weight and height for the 265,725 participants according to the age
at the ﬁrst screening
Age at the ﬁrst
screening (y)
Change in BMI kg/m2
(mean; SD)
Change in weight
kg (mean; SD)
Change in height
cm (mean; SD)
Men
17e20 3.94 (2.64) 14.40 (9.15) 2.4 (3.4)
21e30 2.11 (2.23) 6.92 (7.17) 0.2 (1.3)
31e40 0.95 (1.89) 2.66 (5.83) 0.3 (1.4)
41e50 0.77 (2.05) 1.71 (6.30) 0.8 (1.4)
51e60 0.30 (2.06) 0.05 (6.19) 1.0 (1.4)
Women
17e20 2.49 (3.29) 7.59 (8.99) 1.1 (1.5)
21e30 1.78 (2.80) 5.16 (7.56) 0.4 (1.4)
31e40 0.93 (2.54) 2.20 (6.56) 0.3 (1.5)
41e50 0.68 (2.69) 0.96 (6.96) 1.0 (1.6)
51e60 0.35 (2.84) 2.20 (7.19) 1.5 (1.8)51e60 years at the ﬁrst screening, the quartile with the greatest
BMI change per year had a statistically signiﬁcant increased risk
compared with the quartile with the smallest BMI change per year
(Table IV).
Additional analyses were conducted with the covariates BMI
and height at the ﬁrst screening, categorized into sex-speciﬁc
quartiles, and gave similar results (data not shown). Analyses
with BMI from the ﬁrst screening categorized into quartiles speciﬁc
for each 10-year age group also showed comparable results.
The possibility of an interaction between the ﬁrst measured BMI
and the change in BMI was investigated using an interaction term
and no interaction was found.
Multivariate analysis was conducted with BMI change per year
as a continuous variable (Table V). There was a six-fold increased
relative risk per 1 kg/m2 increase in BMI per year for men aged 20
years or younger at the ﬁrst screening. For men in the older age
groups there was no signiﬁcant increase in risk. There was also
a markedly increased relative risk associated with BMI change per
year for women aged 20 years or younger at the ﬁrst screening. The
relative risk associated with BMI change per year was also elevated,
but to a lesser degree, for women in the age groups 21e30 years,
31e40 years and 51e60 years.
The analyses were also performed using absolute weight change
in kilograms (Table V). The results followed the same trends as
those observed for BMI change per year. An effect of weight gain in
men was only seen in those aged younger than 31 years at the ﬁrst
screening. In the youngest age group, a 10 kg weight gain was
associated with a 33% increased risk of having a THR in men, and
a 24% increased risk in women.
As the ﬁrst screenings were performed over a period of 12 years
(1963e1975), the analysis was repeated stratiﬁed to whether the
ﬁrst screening was early or late in the period, dividing the period in
two by using the median. This did not have any effect on the results
(data not shown).
High BMI at the second screening was not in itself a risk factor
for needing a THR. The mean age at the second screening was 44.6
years. These ﬁndings concur with the ﬁndings in previous studies
where high BMI in the young had a greater impact on the risk for
needing a THR than high BMI in the older age21.
Discussion
This study in a large cohort of men and women showed that
weight gain in young individuals increased the risk of later THR due
Table III
Absolute and relative risk of THR due to primary OA according to BMI change per year in 124,894 men
Quartile of BMI change per year (kg/m2/year)
First <0.04 Second 0.04e0.12 Third 0.12e0.21 Fourth >0.21
17e20 years at ﬁrst screening
No. of participants 4,578 9,879 14,989 17,148
Personeyears 65,174 135,858 202,833 232,764
No. of THR 11 18 31 60
THR per 100,000 personeyears (crude rate) 16.88 13.25 15.28 25.78
Crude relative risk 1 0.78 0.91 1.53
Multivariate-adjusted relative risk [95% conﬁdence interval (CI)]* 1 1.00 (0.46e2.14) 1.23 (0.60e2.51) 2.15 (1.10e4.20)
21e30 years at ﬁrst screening
No. of participants 11,181 11,412 11,347 10,723
Personeyears 184,574 186,172 184,335 174,341
No. of THR 90 78 91 94
THR per 100,000 personeyears (crude rate) 48.76 41.90 49.37 53.92
Crude relative risk 1 0.86 1.01 1.11
Multivariate-adjusted relative risk (95% CI)* 1 1.05 (0.77e1.43) 1.30 (0.96e1.75) 1.37 (1.02e1.85)
31e40 years at ﬁrst screening
No. of participants 8,823 5,032 3,662 3,087
Personeyears 146,688 82,942 60,603 51,506
No. of THR 256 161 128 96
THR per 100,000 personeyears (crude rate) 174.52 194.11 211.21 186.39
Crude relative risk 1 1.11 1.21 1.07
Multivariate-adjusted relative risk (95% CI)* 1 1.13 (0.93e1.38) 1.23 (0.99e1.53) 1.06 (0.84e1.35)
41e50 years at ﬁrst screening
No. of participants 5,001 2,466 1,574 995
Personeyears 79,891 39,114 25,143 16,198
No. of THR 167 88 61 25
THR per 100,000 personeyears (crude rate) 209.03 224.98 242.61 154.34
Crude relative risk 1 1.08 1.16 0.74
Multivariate-adjusted relative risk (95% CI)* 1 1.08 (0.83e1.41) 1.14 (0.85e1.54) 0.74 (0.48e1.13)
51e60 years at ﬁrst screening
No. of participants 1,728 665 394 182
Personeyears 28,889 11,080 6,577 3,038
No. of THR 35 15 10 5
THR per 100,000 personeyears (crude rate) 121.15 135.38 152.05 164.58
Crude relative risk 1 1.12 1.25 1.36
Multivariate-adjusted relative risk (95% CI)* 1 1.19 (0.65e2.18) 1.38 (0.68e2.80) 1.49 (0.58e3.83)
* Adjusted for age, BMI, and height at ﬁrst screening, and for smoking at second screening.
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women older than 30 years at the ﬁrst screening.
One of the strengths of this study is the very large number of
participants. In the older age groups, the number of events was
particularly large, lending the analyses a high statistical power to
detect a possible effect of weight gain. This supports our conclusion
that weight gain is more damaging in the young.
The Norwegian Arthroplasty Register is functioning well, with
a reporting rate of more than 97%30. The register was shown to have
a very high validity when compared with local records from one
hospital31; therefore, the number of undetected events in the
current study population within the follow-up period is likely to be
insigniﬁcant.
Bodyweight and heightweremeasured in a standardizedwayat
a consultation. This standardized measurement circumvented the
problems associated with self-reporting weight and height. These
problems vary systematically with BMI: individuals with a high BMI
tend to under-report their weight and over-report their height32.
A substantial proportion of individuals aged over 80 years may
havemedical conditions that render themunﬁt for surgery, andmay
not receive a THR even if they have severe symptomatic OA;
therefore, all individuals aged over 80 years at the start of follow up
were excluded from the analysis. As some of the individuals might
have received a THR before the start of follow up (1989), the risk set
at the time of an event could be overestimated. This would have the
greatest effect on the oldest age groups, resulting in too low pros-
thesis rates. Accordingly, caution should be exercised when
comparing rates across age categories; however, the effect within
age categorieswould be small and the Cox regression analyses valid.Death is a competing risk when studying the need for THR, and
could lead to an overestimate of the risk for needing a THR,
particularly in the oldest age group. There was no difference in the
number of deaths in the different quartiles in the same age group.
Again, caution should be exercised when comparing rates across
age categories, but within age categories, the Cox regression anal-
yses should be valid.
The mean time between the last weight and height measure-
ments and THRwas 14.9 years (SD5.2).With such a long interval it is
unlikely that weight gain in patients who later received a THR was
caused by early OA symptoms inducing a sedentary lifestyle. To
double check this, further analyses excluded all participants who
had a THR performed before 1995, thus allowing for an even longer
mean time between the weight measurements and surgery. These
analyses gave similar results. Other studies have shown that obesity
precedes the development of OA of the knee joint16,33. Among those
who had their second weight measurement before the start of
follow up, the time between the weight change and the start of
follow up varied. Analyses were conducted including only the
individuals who had their second weight measurement after
January 1 1989, i.e., there was no time gap between the weight
change and start of followup (127,183 individuals). The results were
no longer statistically signiﬁcant; however, the trends in the results
were the same (data not shown). The cohort study of 38,868 indi-
viduals that failed toﬁnd an effect ofweight change between the age
of 35 and 47 years included some of the same individuals in our
cohort, usinghealth surveys performed inNorway19. Themajority of
the individuals from that study are represented in the age group
31e40 years at their ﬁrst screening in our study. Like the previous
Table IV
Absolute and relative risk of THR due to primary OA according to BMI change per year in 140,831 women
Quartile of BMI change per year (kg/m2/year)
First <0.01 Second 0.01 to 0.08 Third 0.08e0.18 Fourth >0.18
17e20 years at ﬁrst screening
No. of participants 9,677 13,018 14,416 14,303
Personeyears 138,795 177,885 193,476 191,981
No. of THR 27 52 49 69
THR per 100,000 personeyears (crude rate) 19.45 29.23 25.33 35.94
Crude relative risk 1 1.50 1.30 1.85
Multivariate-adjusted relative risk (95% CI)* 1 1.88 (1.17e3.02) 1.75 (1.08e2.84) 2.38 (1.51e3.75)
21e30 years at ﬁrst screening
No. of participants 11,596 12,621 13,991 14,570
Personeyears 190,854 205,548 226,175 234,724
No. of THR 136 144 141 200
THR per 100,000 personeyears (crude rate) 71.26 70.06 62.34 85.21
Crude relative risk 1 0.98 0.87 1.20
Multivariate-adjusted relative risk (95% CI)* 1 1.29 (1.02e1.64) 1.21 (0.94e1.54) 1.47 (1.17e1.83)
31e40 years at ﬁrst screening
No. of participants 6,917 5,284 4,660 5,005
Personeyears 113,703 85,911 75,578 81,818
No. of THR 350 287 254 295
THR per 100,000 personeyears (crude rate) 307.82 334.07 336.08 360.56
Crude relative risk 1 1.09 1.09 1.17
Multivariate-adjusted relative risk (95% CI)* 1 1.23 (1.05e1.44) 1.23 (1.04e1.45) 1.26 (1.08e1.47)
41e50 years at ﬁrst screening
No. of participants 4,031 2,900 2,352 1,821
Personeyears 63,140 44,510 36,244 28,543
No. of THR 230 232 164 122
THR per 100,000 personeyears (crude rate) 364.27 521.23 452.49 427.43
Crude relative risk 1 1.43 1.24 1.17
Multivariate-adjusted relative risk (95% CI)* 1 1.46 (1.21e1.75) 1.24 (1.01e1.52) 1.14 (0.91e1.43)
51e60 years at ﬁrst screening
No. of participants 1,858 847 583 358
Personeyears 30,267 13,625 9,485 5,715
No. of THR 81 44 18 26
THR per 100,000 personeyears (crude rate) 267.62 322.94 189.77 454.94
Crude relative risk 1 1.21 0.71 1.70
Multivariate-adjusted relative risk (95% CI)* 1 1.20 (0.82e1.73) 0.71 (0.42e1.18) 1.64 (1.05e2.56)
* Adjusted for age, BMI, and height at ﬁrst screening, and for smoking at second screening.
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although there was some effect for women. The present study has
a greater population, and the follow up period is longer; therefore,
this study captured THRs that were missed in the previous study.
This may explain the difference in the results for women.
In the present study, THR was used as a marker of OA, and
enabled identiﬁcation of participants who developed severely
symptomatic OA, whowanted a joint replacement, and who did not
have contraindications to surgery. This may have introduced a bias
as severe obesity is a relative contraindication to surgery. SuchTable V
Multivariate adjusted relative risk of THR due to primary OA per unit of BMI change
per year, and per 10 kg increase in weight
Age at the ﬁrst
screening (y)
Relative risk/kg/m2/
year (95% CI)*
Relative risk/10 kg
weight gain (95% CI)*
Men
17e20 5.98 (1.79e20.01) 1.33 (1.10e1.60)
21e30 1.82 (0.94e3.53) 1.16 (1.01e1.6.34)
31e40 1.23 (0.77e1.96) 1.10 (0.97e1.26)
41e50 1.40 (0.66e2.97) 1.03 (0.87e1.23)
51e60 5.05 (0.80e32.00) 1.33 (0.90e1.95)
Women
17e20 3.66 (1.71e7.83) 1.24 (1.09e1.41)
21e30 1.86 (1.27e2.72) 1.17 (1.07e1.28)
31e40 1.41 (1.09e1.83) 1.14 (1.05e1.23)
41e50 1.31 (0.88e1.96) 1.08 (0.97e1.19)
51e60 2.41 (1.02e5.73) 1.22 (0.99e1.51)
* Adjusted for age, BMI, and height at ﬁrst screening, and for smoking at second
screening.a bias would presumably work independently of age, and should
not distort the association between age, weight gain, and later THR.
The difference in ﬁndings between men and women, with
women also having a possibly higher risk of THR with weight gain
at older age, may be due to amore complex association between OA
and weight in women. Hormonal and reproductive factors have
been shown to affect the risk of THR in women. Although there are
conﬂicting results on the effect of estrogens on the cartilage34,
increasing parity and early menopause have been shown to
increase the risk of THR35.
Another possible explanation for the increased risk of THR
among the young weight gainers is that their hip joints suffered
a high load for more years than in those who gained weight later in
life. More measurements of each participant in the current study
would have been needed to accurately evaluate this hypothesis. A
biological explanation of the ﬁndings is that the hip joint cartilage
has a changing susceptibility to load throughout life. Wolff’s law
states that bone adapts to different types of loading with a change
in its architecture36, and similar adaptation to load has been
demonstrated in cartilage37. Animal studies have shown that the
cartilage during maturation responds to regular loading with
a positive effect on the collagen architecture38. Loads beyond
a certain threshold, however, will exceed the tissue’s ability to
adapt. Such excess load may induce permanent weakening of the
cartilage. It is possible that in the hip joint this threshold is not
constant throughout life. If the threshold is lower during the ﬁrst
decades of life, overweight at this agewould increase the risk of hip
OAmore than overweight in old age. In the current study, there has
been no adjustment for other known risk factors for THR like
H. Apold et al. / Osteoarthritis and Cartilage 19 (2011) 809e815814physical activity, family history of OA, and previous joint injury. It
could be that young participants appeared to be more affected by
weight gain only because they were more physically active. A
strong relationship between low physical activity and obesity is
well documented39. As a high level of physical activity is unlikely
among the overweight, it is not considered to be a major cause for
hip OA in this group.
There is already good evidence that a high BMI increases the risk
of later THR due to primary hip OA20,21. To our knowledge this is the
ﬁrst study that also demonstrates an adverse effect on the hip joint
of a BMI increase, and that this effect is most signiﬁcant when the
weight gain occurs at a young age. This concurs with our previous
study in which THR was shown to have no association with BMI
changes that occurred during the fourth and ﬁfth decades of life19.
Obesity is spreading, and the young population is severely
affected40,41. We have found that weight gain during early adult-
hood is particularly associatedwith severely symptomatic OA of the
hip. This indicates that addressing early obesity and weight gain is
particularly important in preventing the development or progres-
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